Late thrombosis after polymer-based sirolimus-(Cypher) and paclitaxel-eluting (Taxus) drug eluting stents has emerged as a major safety concern. This review will summarize our current understanding of the vascular response to these DES in both humans and animals, especially as it pertains to the issue of late DES thrombosis. ььььььььььььььььььььььь 1511
Acyclic Retinoid Inhibits Neointima Formation Through Retinoic Acid Receptor Beta-Induced Apoptosis
Nanae Kada, Toru Suzuki, Kenichi Aizawa, Takayoshi Matsumura, Naoto Ishibashi, Naomi Suzuki, Norifumi Takeda, Yoshiko Munemasa, Daigo Sawaki, Takashi Ishikawa, Ryozo Nagai ььььььььь 1535 Acyclic retinoid (ACR) is a synthetic retinoid with a high safety profile that has been pursued with high expectations for therapeutic use in prevention (recurrence) and treatment of malignancies. With the objective of addressing the therapeutic potential in the cardiovasculature, namely neointima formation, effects of ACR on neointima formation and the involved mechanisms were investigated.
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Pauline Ocaya, Andreas C. Gidlöf, Peder S. Olofsson, Hans Törmä, Allan Sirsjö ьььььььььььььььььььььььььь 1542 atRA regulates proliferation and differentiation of various cell types. We show that inhibition of CYP26 by R115866 in intimal SMCs results in increased cellular retinoids and retinoidal effects, ie, inhibition of DNA synthesis and alteration of cell morphology. Therefore, CYP26 inibitors offer a potential new therapeutic approach to vascular proliferative disorders. Hideki Ohtsubo, Toshihiro Ichiki, Ryohei Miyazaki, Keita Inanaga, Ikuyo Imayama, Yasuko Hashiguchi, Junichi Sadoshima, Kenji Sunagawa ььььь 1549 Inducible cAMP early repressor (ICER) is involved in beraprost-induced growth inhibition of vascular smooth muscle cells. Overexpression of ICER suppressed neointimal formation in balloon-injured artery, suggesting that ICER may be an important negative regulator of the vascular remodeling process and an effective therapeutic tool to treat vascular proliferative disease.
Inducible cAMP Early Repressor Inhibits Growth of Vascular Smooth Muscle Cell

